Showing results (331-340 of 352) with videos related to

Sort By:
Pageof 36
British Journal of Haematology|August 18, 2021
PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort studyFei-Fei Tang, Sheng-Ye Lu, Xiao-Su Zhao, et al.
International Journal of Clinical and Experimental Medicine|July 12, 2013
Brain-derived neurotrophic factor is up-regulated in severe acute cauda equina syndrome dog modelJun-Ming Tan, Jianxin Wu, Jian-Gang Shi, et al.
Cytokine|March 18, 2008
IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cellsWen Jie Zhang, Ben Hui Li, Xian Zi Yang, et al.
Autophagy|February 21, 2023
MoVast2 combined with MoVast1 regulates lipid homeostasis and autophagy in Magnaporthe oryzaeXue-Ming Zhu, Lin Li, Jian-Dong Bao, et al.
Journal of Agricultural and Food Chemistry|June 10, 2025
FK506 Targets MoFpr1 to Modulate Autophagy and Ubiquitination, Inhibiting the Pathogenicity of Magnaporthe oryzaeWen-Hui Zhao, Jiong-Yi Yan, Ke-Xin Xie, et al.
Mbio|August 22, 2019
Metabolomics Analysis Identifies Sphingolipids as Key Signaling Moieties in Appressorium Morphogenesis and Function in Magnaporthe oryzaeXiao-Hong Liu, Shuang Liang, Yun-Yun Wei, et al.
World Journal of Pediatrics : WJP|January 1, 2013
Incidence of brain injuries in premature infants with gestational age ≤ 34 weeks in ten urban hospitals in ChinaHui-Jin Chen, Ke-Lun Wei, Cong-Le Zhou, et al.
Scientific Reports|September 26, 2025
Mechanisms of Saposhnikovia divaricata in attenuating NaAsO2-induced neural injury via the PI3K/AKT pathwayDan Gu, Xian-Li Chen, Heng-Lin He, et al.
Leukemia & Lymphoma|July 1, 2021
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemiaHao Jiang, Xiao-Hong Liu, Jun Kong, et al.
British Journal of Haematology|April 27, 2024
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapyFei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, et al.
Pageof 36